A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 21
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AMI
Long Form : amifostine
No. Year Title Co-occurring Abbreviation
2020 Radioprotective Effects of Amifostine, L-Carnitine and Vitamin E in Preventing Early Salivary Gland Injury due to Radioactive Iodine Treatment. EVIT, i.p, IM, LC, PS, RIT, SG
2019 Amifostine inhibited the differentiation of RAW264.7 cells into osteoclasts by reducing the production of ROS under 2 Gy radiation. ROS
2019 Amifostine Suppresses the Side Effects of Radiation on BMSCs by Promoting Cell Proliferation and Reducing ROS Production. BMSCs
2017 Zytoprotektion mit Amifostin (Ethyol) in der Chemotherapie: Meta-Analyse zum pharmakokinetischen Interaktionspotential mit Zytostatika. ---
2016 Histopathological and biochemical comparisons of the protective effects of amifostine and l-carnitine against radiation-induced acute testicular toxicity in rats. LC, MDA, MSTDs, RT
2013 Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats. CDS, DOX
2011 Acute radiation effect in the brain in infant rats: Neurocognitive and histopathological examination. RT
2011 L-Carnitine Protection Against Cisplatin Nephrotoxicity In Rats: Comparison with Amifostin Using Quantitative Renal Tc 99m DMSA Uptake. CAR, CIS, MDA
2010 The protection of the myocardium by amifostine against mitoxantrone-induced acute cardiotoxicity in rats. i.p, MDA, MITO
10  2007 Use of amifostine in the treatment of recurrent solid tumours in children. ICE
11  2006 cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib. ---
12  2005 Additive apoptotic effect of STI571 with the cytoprotective agent amifostine in K-562 cell line. ---
13  2005 Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index. Cys, MEFs, PAC
14  2005 Influence of the cyto-protective agent amifostine on the pharmacokinetics of low-dose Paclitaxel. AUC, NSCLC, PAC, PHK
15  2005 Radiopharmaceutical model using 99mTc-MIBI to evaluate amifostine protection against doxorubicin cardiotoxicity in rats. DOX
16  2004 Amifostine protection against doxorubicin cardiotoxicity in rats. DOX
17  2004 Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy. EI
18  2003 Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. ALA, NAC, OS
19  2002 A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients. Mel
20  2002 Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy. EI
21  2001 Clinical pharmacokinetics and metabolism of paclitaxel after polychemotherapy with the cytoprotective agent amifostine. PACLI, PHK